Product image of Gliadel (Carmustine) supplied by GNH India

Gliadel

Active Ingredient:
Carmustine
Origin:
EU

Gliadel (Carmustine)

Gliadel is an intralesional implant used in cancer treatment. It contains carmustine, a chemotherapy agent designed for localized delivery. This product is manufactured by Clinigen Healthcare B.V. and is intended for specific medical applications.

Manufacturer / TM Owner

Clinigen Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Gliadel is primarily used in the treatment of certain types of brain tumors. It is designed to deliver carmustine directly to the tumor site, providing localized chemotherapy. This approach aims to target cancer cells while minimizing systemic exposure. Gliadel is often considered for use in conjunction with other cancer treatments.

Side Effects

  • Gliadel implants are designed to release carmustine over time, which may help in reducing tumor size. The effects of Gliadel are intended to be localized, targeting the area where the implant is placed. As with any medical treatment, individual responses can vary, and it is important to discuss potential outcomes with a healthcare provider.

Precautions & Warnings

  • Gliadel should be handled with care, following the guidelines provided by healthcare professionals. It is crucial to ensure that the implant is placed correctly to achieve the desired effects. Patients should be monitored for any signs of adverse reactions and should follow up with their healthcare provider as recommended.

Avoid Interactions

  • Gliadel may interact with other medications or treatments, so it is important to inform your healthcare provider about all current medications. Certain drugs, including those that affect the immune system or blood clotting, may require special consideration when used with Gliadel. Always consult a healthcare professional for personalized advice.

Frequently Asked Questions

Gliadel is used in the treatment of certain types of brain tumors, delivering carmustine directly to the tumor site.

Gliadel implants release carmustine over time, providing localized chemotherapy to target cancer cells.

Gliadel is manufactured by Clinigen Healthcare B.V.

Gliadel is designed to release carmustine to help reduce tumor size, with effects intended to be localized.

Gliadel should be handled with care and placed correctly by a healthcare professional, with monitoring for adverse reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Carmustine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT